Instaflex-BR Tablet DT is a combination pharmaceutical formulation containing Bromelain (180 mg), Trypsin (96 mg), and Rutoside (200 mg), designed to provide anti-inflammatory and analgesic effects primarily in musculoskeletal disorders. Bromelain, a proteolytic enzyme derived from pineapple stems, exhibits potent anti-inflammatory and fibrinolytic properties, aiding in the reduction of edema and pain associated with soft tissue injuries. Trypsin, another proteolytic enzyme, facilitates the breakdown of proteins involved in inflammatory processes, thereby enhancing tissue repair and reducing inflammation. Rutoside, a bioflavonoid, contributes to vascular protection by strengthening capillary walls and exerting antioxidant effects, which help in minimizing oxidative stress and improving microcirculation. The combination of these agents in Instaflex-BR Tablet DT offers synergistic benefits in managing conditions such as arthritis, tendonitis, and post-traumatic swelling. The tablet is designed for rapid disintegration, ensuring prompt onset of action and improved patient compliance. It is indicated as an adjunct therapy for inflammatory and degenerative joint diseases, soft tissue injuries, and other inflammatory conditions where reduction of pain, swelling, and oxidative damage is desired. Use should be guided by a healthcare professional, considering patient-specific factors and potential contraindications.